RIZZO, MICHELANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.395
EU - Europa 2.172
AS - Asia 1.278
SA - Sud America 248
AF - Africa 68
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.364
RU - Federazione Russa 1.031
SG - Singapore 395
IE - Irlanda 340
HK - Hong Kong 325
SE - Svezia 309
CN - Cina 221
BR - Brasile 212
KR - Corea 191
IT - Italia 107
FI - Finlandia 97
UA - Ucraina 71
GB - Regno Unito 66
DE - Germania 65
IN - India 60
AU - Australia 59
CI - Costa d'Avorio 47
CH - Svizzera 43
CA - Canada 21
VN - Vietnam 18
TR - Turchia 15
AR - Argentina 13
FR - Francia 12
BD - Bangladesh 11
IQ - Iraq 9
EC - Ecuador 8
JP - Giappone 7
PE - Perù 7
PL - Polonia 7
NL - Olanda 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
MX - Messico 4
SC - Seychelles 4
BH - Bahrain 3
PY - Paraguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CD - Congo 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
MU - Mauritius 2
NP - Nepal 2
PK - Pakistan 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BG - Bulgaria 1
BJ - Benin 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
KG - Kirghizistan 1
LB - Libano 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.222
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.755
Dublin 340
Chandler 306
Hong Kong 249
Fairfield 232
Singapore 230
Seoul 184
Ashburn 131
Buffalo 130
Jacksonville 115
Woodbridge 109
Cambridge 108
Dallas 93
Seattle 92
Wilmington 88
Princeton 86
Boston 83
Beijing 77
Houston 64
Boardman 63
Melbourne 58
Ann Arbor 57
Abidjan 47
Mumbai 45
Bern 43
Los Angeles 41
Hefei 35
Moscow 28
Medford 24
Redondo Beach 23
Shanghai 21
Falls Church 20
Munich 20
Toronto 16
Kent 13
São Paulo 13
Andover 12
San Diego 12
Hillsboro 10
Lawrence 10
Norwalk 10
The Dalles 10
Florence 9
Brooklyn 8
New York 8
Altamura 7
Izmir 7
Milan 7
Portsmouth 7
Rio de Janeiro 7
Tokyo 7
Turku 7
Lima 6
London 6
Tianjin 6
Warsaw 6
Yubileyny 6
Brasília 5
Brussels 5
Campo Grande 5
Dhaka 5
Guayaquil 5
Paris 5
San Francisco 5
San Marzano di San Giuseppe 5
Atlanta 4
Casablanca 4
Curitiba 4
Frankfurt am Main 4
Hanoi 4
Helsinki 4
Manchester 4
Montreal 4
Porto Alegre 4
West Jordan 4
Amsterdam 3
Belo Horizonte 3
Bengaluru 3
Campinas 3
Chicago 3
Council Bluffs 3
Denver 3
Duncan 3
Erbil 3
Gravataí 3
Ho Chi Minh City 3
Laurel 3
Lauterbourg 3
Lewisham 3
Maletto 3
Marília 3
Redwood City 3
Ribeirão Preto 3
Salerno 3
São José dos Campos 3
Tashkent 3
Amman 2
Baghdad 2
Baku 2
Belém 2
Totale 5.358
Salva come PNG Salva come JPEG
Nome #
M-VEC chemotherapy: new perspectives in the treatment of bladder cancer 167
Imperative indications for conservative surgery for renal cell carcinoma: 20 years' experience. 164
Localization of endothelin-converting enzyme-1 in human kidney 161
The role of lomefloxacin in the treatment of chronic prostatitis. 159
Computerized in vivo research from the growth of urease-producing bacteria in the presence of antibiotics combined with propionhydroxamic acid 142
Complete androgen blockade as treatment for advanted prostate cancer: clinical response and side-effects 135
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 132
A combination of chemotherapy with M-VEC (methotrexate, vinblastine, epirubicin, cisplatin) in the treatment of metastatic carcinoma of the bladder [POLICHEMIOTERAPIA CON M-VEC (METOTRESSATO, VINBLASTINA, EPIRUBICINA, CISPLATINO) NEL TRATTAMENTO DEI PAZIENTI CON CARCINOMA VESCICALE METASTATICO] 126
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 125
Antibacterial activity of succinyl-norfloxacin in urinary infections: a comparative study 123
Apparato Urogenitale 122
Anomalie di sviluppo 122
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 121
A phase III study of recombinant leukocyte alpha Inteferon and Vinblastine in metastatic renal cell carcinoma. Preliminary report. 121
Conservative surgery of renal cell carcinoma: a retrospective analysis of 25 years of experience 121
URINARY SYMPTOMS, QUALITY OF LIFE AND SEXUAL FUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY BEFORE AND AFTER PROSTATECTOMY: A PROSPECTIVE STUDY 120
Anomalie di sviluppo 120
Alterazioni della minzione 120
Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. 119
Ureteral intussusception by a fibroepithelial polyp. 119
Alterazioni della minzione 119
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 117
Apparato Urogenitale 117
Early diagnosis and monitoring of superficial transitional call carcinoma by microsatellite analysis on urine sediment 116
Calcolosi urinaria 115
ADAPTIVE MORPHOLOGICAL CHANGES OF THE INTESTINAL MUCOSA IN ORTHOTOPIC ILEAL BLADDERS. SHORT-TERM AND LONG-TERM EVALUATION. 113
Leiomyoma of the corona glans penis. 111
Epidemiology and risk factors in urolithiasis 111
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer 109
Benign prostate hypertrophy and sexual activity: evaluation of prostate symptoms (IPSS) and erectile function (IIEF). 106
Long-term results of anterior and posterior urethroplasty with actuarial evaluation of the success rates 106
Surgical treatment of bilateral large seminal vesicle cysts associated with unilateral renoureteral agenesis 105
The psoas bladder Hitch procedure in ureter lesions [LA PSOAS BLADDER HITCH NELL LESIONI DELL'URETERE] 103
Giant stone in enterocystoplasty 102
Pathophysiology of reno-ureteral colic 102
Patologia dell'apparato genitale maschile 101
Calcolosi urinaria 100
cisti e lesioni vascolari 100
P53 gene mutations in transitional cell bladder carcinoma. 99
Ureterouterine fistula as a complication of cesarean section 96
Surgical repair of extensive ureteral loss by renal autotransplantation 95
Urethral carcinoma recurrence in ileal orthotopic neobladder:urethrectomy and conversion in a continent pouch with abdominal stoma 94
The role of molecular biology in bladder and prostatic carcinoma 93
Natural history of renal cell carcinoma 93
Biology and paraneoplastic syndromes of renal carcinoma [BIOLOGIA E SINDROMI PARANEOPLASTICHE DEL CARCINOMA RENALE] 92
Cisti e lesioni vascolari 90
Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. 90
The treatment of primary neoplasm of the ureter. A review of sixty cases [IL TRATTAMENTO DELLE NEOPLASIE PRIMITIVE DELL'URETERE: REVISIONE DI 60 CASI] 85
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. 85
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections 84
Infezioni delle vie urinarie 78
Traumi dell'apparato urogenitale 78
Incidental prostatic carcinoma after suprapubic prostatectomy: Clinical and pathological evaluation 75
Morphologic evaluation of urinary stones in patients with recurrent stone formation [VALUTAZIONE MORFOLOGICA DEI CALCOLI URINARI NEI PAZIENTI ABITUALI FORMATORI DI CALCOLI] 75
Correlations between cytogenetic analysis and static cytometry in renal carcinoma [CORRELAZIONI FRA ANALISI CITOGENETICA E CITOMETRIA STATICA NEL CARCINOMA RENALE] 74
Interferon alpha 2A in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study 73
Therapy of uncomplicated urogenital infections: Comparative study between norfloxacin, enoxacin and ofloxacin [TERAPIA DELLE INFEZIONI URO-GENITALI NON COMPLICATE: STUDIO COMPARATIVO APERTO FRA NORFLOXACINA, ENOXACINA ED OFLOXACINA] 73
Recurrent calcium nephrolithiasis: Variations in the structure and growth of urinary crystals [NEFROLITIASI CALCICA RECIDIVANTE: VARIAZIONI NELLA STRUTTURA E NELLA CRESCITA DEI CRISTALLI URINARI] 73
Lesioni ostruttive 72
Interferon alpha 2 a and vinblastine in th treatment of metastatic renal carcinoma 72
Neo-adjuvant M-VEC chemotherapy in the treatment of bladder cancer: our experience on 12 patients 71
Intravesical immunotherapy with alpha 2A Interferon in patients with superficial bladder tumors. 71
Tumori dell'apparato urinario 71
Lesioni ostruttive 71
Conservative surgery of renal cell carcinoma: Evaluation of the prognostic factors 70
Mepartricin in the treatment of benign prostatic diseases: Four years experience 70
Painless non invasive lithotripsy of pelvic and iuxtavesical ureteral stones 70
Somatomedin C in the seminal plasma of subjects with azoospermia 70
Leuprolide depot in treatment of advanced prostatic carcinoma: a dose related clinical and endocrinological evaluation. 70
Il trapianto renale nei pazienti a rischio 69
Correlations between multiple rectal examination, PSA, transrectal echography and Gleason score in the screening of suspected prostatic carcinoma [CORRELAZIONI FRA ESPLORAZIONE RETTALE MULTIPLA, PSA, ECOGRAFIA TRANSRETTALE E GLEASON SCORE NELLO SCREENING DEL NODULO PROSTATICO SOSPETTO] 69
Intravesical immunotherapy with alpha 2A Interferon in patients with superficial bladder tumors. 69
The role of interferons in the treatment of urinary tract cancer [IL RUOLO DEGLI INTERFERONI NEL TRATTAMENTO DELLE NEOPLASIE UROLOGICHE] 69
Intra-operative antibiotic perfusion in the renal artery in patients with infection induced staghorn calculi 68
Patologia dell'apparto genitale maschile 67
Renal autotransplantation in reconstructive surgery of the ureter [L'AUTOTRAPIANTO RENALE NELLA CHIRURGIA RIPARATIVA DELL'URETERE] 67
Intravesical antiblastic prophylaxis: Inteferon alpha . 4 epidoxorubicin versus 4 epidoxorubicin. Results of a randomized study [PROFILASSI ANTIBLASTICA ENDOVESCICALE: INTEFERONE ALFA + 4 EPIDOXORUBICINA VERSUS 4 EPIDOXORUBICINA. RISULTATI DI UNO STUDIO RANDOMIZZATO] 67
Modulation of the role of androgens in the production of growth factor receptors in the prostatic tissue of men with prostate hyperplasia [MODULAZIONE DA PARTE DEGLI ANDROGENI DELLA PRODUZIONE DI RECETTORI PER I FATTORI DI ACCRESCIMENTO NEL TESSUTO PROSTATICO DI PROSTATE IPERPLASTICHE] 66
Vascular disease, trauma and infections of the retroperitoneum (except retroperitoneal fibrosis) [PATOLOGIA VASCOLARE, TRAUMATICA E SINDROMI INFIAMMATORIE DEL RETROPERITONEO (ESCLUSA LA FIBROSIS RETROPERITONEALE)] 66
The role of recombinant Interferon alpha 2 A in endocavitary prophylaxis of superficial bladder tumors. 66
Infezioni delle vie urinarie 65
Tumori dell'apparato urinario 65
The role of fluoro-deoxyuridine (FUDR) in continuous circadian administration in the therapy of metastatic renal carcinoma: Our experience in 10 cases [IL RUOLO DELLA FLUORODESOSSIURIDINA (FUDR) IN SOMMINISTRAZIONE CIRCADIANA CONTINUA NELLA TERAPIA DEL CARCINOMA RENALE METASTATICO: NOSTRA ESPERIENZA SU 10 CASI] 64
Traumi dell'apparato urogenitale 63
Frequently isolated uropathogenic strains and antibiotic resistance: An essential basis to a rational therapeutic approach in urinary tract infections [FREQUENZA DI ISOLAMENTO DEI GERMI UROPATOGENI ED ANTIBIOTICORESISTENZA: PREMESSE INDISPENSABILI AD UN APPROCCIO TERAPEUTICO RAZIONALE DELLE INFEZIONI URINARIE] 63
Prostatectomia radicale retropubica nerve sparing: modifiche di tecnica 63
null 43
Totale 8.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 0 8 83 12 26 40 55 43 19
2021/2022454 2 69 1 25 12 9 10 25 14 8 101 178
2022/20231.177 150 80 44 75 110 255 186 82 105 5 32 53
2023/2024350 14 60 92 29 15 36 6 52 3 11 15 17
2024/20253.725 120 327 203 430 1.407 611 44 224 145 57 85 72
2025/20261.220 291 442 230 160 97 0 0 0 0 0 0 0
Totale 8.234